Search results
GSK chief shrugs off concerns that FTSE bosses are not paid enough
The Telegraph via Yahoo Finance· 5 days agoThis was before shareholders last week agreed to more than double his maximum pay to as much as...
GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line
Market Watch· 5 days agoThe British firm beat analysts’ forecasts in posting a 17% increase in its core operating profits,...
Biotech’s bind over China bill
Politico· 2 days agoMODERNA BULLISH ON RSV SHOT — Moderna executives signaled confidence Thursday that the drugmaker’s RSV vaccine can compete with shots already on the market if the FDA approves ...
Letters: The Conservative Party no longer represents the views of its members
The Telegraph via Yahoo News· 4 days agoSIR – Sir Graham Brady, chairman of the Conservative Party’s 1922 Committee, would like the choice...
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant...
Benzinga· 4 days agoBeyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 4 days agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Why Moderna Partnered with OpenAI
Analytics India Magazine· 7 days agoModerna plans to use ChatGPT Enterprise for mRNA medicine development to launch up to 15 new products in the next five years, including a vaccine for RSV...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 1 day agoDiscover the latest findings on the return on investment from pharmaceutical...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks· 6 days agoThe Earnings Trends report indicates that as of Apr 24, 16.7% of the companies in the Medical sector — representing 32.6% of the sector’s market capitalization — reported quarterly earnings.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 6 days agoSHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer: NNVC ) (the "Company"),...
